Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Quetiapine vs Haloperidol in Schizophrenia


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 3,651

Availability: In stock

  • Product Description

Quetiapine, a dibenzothiazepine derivative, is a novel antipsychotic with demonstrated efficacy in acute schizophrenia. It is closest to Clozapine in its pharmacological profile but is free of the life threatening side effects like agranulocytosis. It may well replace Clozapine in the treatment of refractory schizophrenia and in bringing some miraculous improvements (awakening) in chronic schizophrenia. In addition to improvement in positive and negative symptoms it has also exhibited a beneficial effect for treatment of affective and cognitive dysfunctions in patients of schizophrenia. The salient feature of quetiapine is tolerability in terms of EPS, absence of any effect on prolactin levels and minimal effect on weight, that differentiate it from the other available antipsychotic drugs. Preliminary studies indicate that there is a high level of patient acceptability and satisfaction with quetiapine. Overall, quetiapine is as effective as risperidone or olanzapine for the treatment of psychotic symptoms, and is more effective for the treatment of depressive symptoms. It has an excellent risk/benefit profile and is a suitable first-line option for the treatment of schizophrenia.

Product Specifications
SKU :COC94840
AuthorRavi Paul and Lavina Prashar
Number of Pages108
Publishing Year2011-11-25T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-08-14 00:00:00